Abstract
(Int J Obstet Anesth. 2015;24:237–246) Neostigmine, an acetyl-cholinesterase inhibitor, has been used for both epidural and intrathecal anesthesia in obstetric patients. In order to quantify its benefits and/or adverse effects as an adjuvant in neuraxial anesthesia, the authors of this meta-analysis reviewed randomized, placebo-controlled studies in which neostigmine was administered in combination with local anesthetics or other adjuvants.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
